Key result
The synthetic ryanoid 21-amino-9alpha-hydroxy-ryanodine reversibly interacts with the high-affinity ryanodine binding site on sheep cardiac Ca2+-release channels in a voltage-dependent manner.
The synthetic ryanoid 21-amino-9alpha-hydroxy-ryanodine interacts reversibly with cardiac ryanodine receptors, revealing novel voltage-dependent and state-dependent binding mechanisms.
Answers are grounded in this paper and cite their sources.
May inform synthetic ryanoid design for RyR modulation; leaves open translation to human cardiac disease.
The binding of ryanodine to a high affinity site on the sarcoplasmic reticulum Ca2+-release channel results in a dramatic alteration in both gating and ion handling; the channel enters a high open probability, reduced-conductance state. Once bound, ryanodine does not dissociate from its site within the time frame of a single channel experiment. In this report, we describe the interactions of a synthetic ryanoid, 21-amino-9alpha-hydroxy-ryanodine, with the high affinity ryanodine binding site on the sheep cardiac sarcoplasmic reticulum Ca2+-release channel. The interaction of 21-amino-9alpha-hydroxy-ryanodine with the channel induces the occurrence of a characteristic high open probability, reduced-conductance state; however, in contrast to ryanodine, the interaction of this ryanoid with the channel is reversible under steady state conditions, with dwell times in the modified state lasting seconds. By monitoring the reversible interaction of this ryanoid with single channels under voltage clamp conditions, we have established a number of novel features of the ryanoid binding reaction. (a) Modification of channel function occurs when a single molecule of ryanoid binds to the channel protein. (b) The ryanoid has access to its binding site only from the cytosolic side of the channel and the site is available only when the channel is open. (c) The interaction of 21-amino-9alpha-hydroxy-ryanodine with its binding site is influenced strongly by transmembrane voltage. We suggest that this voltage dependence is derived from a voltage-driven conformational alteration of the channel protein that changes the affinity of the binding site, rather than the translocation of the ryanoid into the voltage drop across the channel.
No takes yet. Share an insight, caveat, or question.
Tanna et al. (1998) studied this question. 21-amino-9alpha-hydroxy-ryanodine vs. ryanodine was evaluated on Channel function modification and binding characteristics. The synthetic ryanoid 21-amino-9alpha-hydroxy-ryanodine reversibly interacts with the high-affinity ryanodine binding site on sheep cardiac Ca2+-release channels in a voltage-dependent manner.
Synapse has enriched 10 related papers. Consider them for comparative context: